You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國同輻(01763.HK):放射源研發生產基地成功獲批輻射安全許可證

格隆匯8月22日丨中國同輻(01763.HK)發佈公告,近日,中國同輻旗下附屬公司四川中核同源科技有限公司的放射源研發生產基地成功獲批輻射安全許可證,正式具備放射源生產、銷售等相關資質,產品將逐步面向市場。

該項目是亞洲最大的放射源研發生產基地,建設包括碳-14源、氪-85源等13條放射源生產線,該項目建成後年產放射源將超過10萬枚。中國同輻將聚集國內主要放射源的研發、生產資源,向國內外提供超過70種核素的高質量放射源產品,可提供放射源資源再利用服務、輻照服務等,爲我國工業、農業、醫學、國防以及航空航天等領域的射線技術應用做出積極貢獻。

未來,中國同輻將高標準推動該項目的二期建設,進一步擴大產能規模、豐富產品譜系,計劃新增鐦-252、銫-137、鎇-241等放射源生產線,全方位滿足市場多元化需求。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account